MwanzoONC • TSE
add
Oncolytics Biotech Inc
Bei iliyotangulia
$ 0.81
Bei za siku
$ 0.76 - $ 0.80
Bei za mwaka
$ 0.67 - $ 2.08
Thamani ya kampuni katika soko
61.62M CAD
Wastani wa hisa zilizouzwa
elfu 56.13
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 8.44M | -4.66% |
Mapato halisi | -8.02M | -103.01% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.10 | 9.91% |
EBITDA | -8.43M | 4.56% |
Asilimia ya kodi ya mapato | -0.29% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.94M | -54.34% |
Jumla ya mali | 20.19M | -48.00% |
Jumla ya dhima | 14.20M | 26.18% |
Jumla ya hisa | 5.98M | — |
hisa zilizosalia | 86.42M | — |
Uwiano wa bei na thamani | 11.57 | — |
Faida inayotokana na mali | -94.91% | — |
Faida inayotokana mtaji | -245.72% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -8.02M | -103.01% |
Pesa kutokana na shughuli | -7.85M | -28.12% |
Pesa kutokana na uwekezaji | elfu -6.00 | -100.00% |
Pesa kutokana na ufadhili | 3.34M | 91.68% |
Mabadiliko halisi ya pesa taslimu | -3.66M | 27.88% |
Mtiririko huru wa pesa | -4.62M | 44.28% |
Kuhusu
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Ilianzishwa
1998
Makao Makuu
Tovuti
Wafanyakazi
28
